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Original Article   
 
CenoDerm vs. Fascia lata for the Prevention of Dorsal Nasal 
















Dorsal nasal irregularity is a complication of rhinoplasty surgery, mostly seen in patients with 
thin skin. Acellular dermis (CenoDerm) and homologous fascia lata covering the nasal bone 
cartilage structure have been used to achieve a smooth surface. In this study, we aimed to 
investigate clinical outcomes using these two materials.  
 
Materials and Methods:  
After a standard rhinoplasty procedure, a layer of the acellular dermis or homologous fascia 
lata was placed in the pocket of the dorsum. Patients were evaluated for clinical outcomes at 
3, 6, and 12 months after the procedure.  
 
Results:  
Forty-two of 68 patients completed the follow-up period. Patient satisfaction was higher in 
the homologous fascia lata group. Similarly, nasal dorsum inspection and palpation results 
were better in the homologous fascia lata group compared with the CenoDerm group but was 
significant in palpation (P=0.00). There was no complete absorption in the homologous fascia 
lata group 6 months after surgery (P= 0.04 vs. CenoDerm) but no significant difference was 
observed at 12 months. 
 
Conclusion:  
Homologous fascia lata is better than acellular dermis in preventing dorsal nasal irregularity 
after rhinoplasty in thin-skinned patients.  
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Introduction 
Irregularities and adhesions to the 
underlying structures in the nasal dorsum 
may be seen after rhinoplasty surgery or 
nasal trauma. Dorsal irregularity is reported 
to occur in 7–10% of all primary 
rhinoplasties, requiring revision surgery. 
Thin skin is the major risk factor (1). Grafts 
are available in the forms of autologous, 
homologous, and allogenic tissues that are 
used for both the prevention and correction 
of dorsal nasal irregularities, particularly in 
the thin-skinned patients. Increased risk of 
infection, extrusion, and late inflammation 
are all drawbacks of alloplastic materials (2). 
Autologous fascia is used for onlay grafts at 
the radix and dorsum; however harvesting 
autologous fascia requires an additional 
incision and procedure (3). Homologous 
fascia, such as Tutoplast-processed fascia 
lata (TPFL), is not associated with 
harvesting morbidity or additional operating 
time (3). Many clinical studies have shown 
the stability of fascia grafts and their good 
tolerability after transplantation. However, 
differing absorption rates have been 
reported. Based on previous studies, 
acellular dermis is easy to use and does not 
change over time. In addition, acellular 
dermis is soft, thin, pliable, and natural (4). 
Few clinical studies have investigated the 
material absorption rate of fascia grafts, and 
those that are reported are insufficient 
because of limitations of objective 
assessment of the materials. To date, there 
have been no studies to compare the clinical 
outcome of a homologous fascia lata graft vs 
acellular dermis graft for the prevention of 
dorsal nasal irregularities. In this 
randomized clinical trial, acellular dermis 
and homologous fascia lata grafts are used 
as onlay grafts, and their effectiveness in the 
prevention of nasal dorsal irregularities after 
a rhinoplasty procedure is investigated. It 
was considered that if these products 
demonstrated good efficacy, this may 
provide a viable new option for the surgeon 
and patient as the graft is easy to use, does 
not require harvesting procedures, and is not 
subject to allogenic complications. 
 
Materials and Methods 
Subjects: This study was conducted in a 
private clinic between 2013 and 2015. The 
trial was registered at the Iranian Registry of 
Clinical Trials with registration number 
IRCT 20140 41717312N1.  
Thin-skinned patients over 18 years of age, 
with a dorsal nasal hump without 
modification of the radix, were enrolled for 
rhinoplasty. The assessment of thin skin was 
confirmed by two expert surgeons on 
inspection and palpation. After a thorough 
explanation of the materials and methods, 
patients who agreed to become a study case 
in this randomized clinical trial were 
recruited, and all provided signed written 
informed consent. Patients with a previous 
history of rhinoplasty or other surgery on the 
nose, nasal trauma and fracture, diabetes 
mellitus, immunologic diseases, or vascular 
and hemorrhagic disease were excluded. 
Patients were divided into two groups of 34 
using a permuted block randomization 
method, and remained blinded with respect 
to the technique performed on them. 
Surgeries were performed by the same 
surgeon in all cases (first author). Because of 
the nature of the intervention, the surgeon 
could not be blinded with respect to the 
procedure. To prevent possible bias, the 
surgeon was committed to perform the 
procedure in an exactly randomized manner, 
and he was not permitted to change the 
surgical plan for any individual in the 
operating room.  
 
Graft Processing 
The following steps were followed for graft 
processing. 1) Case selection; 2) Tissue 
harvesting and processing in a sterile room; 
3) Tissue assessment using several 
microbiologic and serologic tests;  
4) Delipidization in both grafts and hair 
removal in the case of CenoDerm;  
5) Rendering the graft acellular; 6) Freezing 
of the graft at-60-80°C and drying (<0.5 
water activity); 6) Gamma irradiation. 
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Surgical Procedures 
After elevating the skin flap and removal 
of the dorsal hump without modification of 
the radix, the requirement for correction in 
each patient was evaluated. Then, at the 
end of surgery, a layer of acellular dermis 
(Ceno Derm; Tissue Regeneration 
Corporation, Tehran, Iran) or homologous 
fascia lata (Fascia Lata;Tissue Regeneration 
Corporation, Tehran, Iran), with a thickness 
of 0.6–0.9 mm and measuring 20×40 mm, 
was placed in the pocket of the dorsum. 
 
Assessment of Surgical Outcome 
Standardized color photographs of each 
patient were taken before and after the 
rhinoplasty procedure and 3, 6, and 12 
months after the procedure. Patients were 
evaluated for signs of infection, seroma 
formation, extrusion, and migration of 
materials by a physician who was not 
involved in the treatment. To assess 
absorption rate as the primary outcome of 
the study, the dorsal height was measured 
using Teb Negar Cosmetic Simusurge 
computer software,6 and 12 months after 
surgery. Measurements were performed on 
right lateral photographs (Fig.1).  
 
 
Fig1: a) Standard Frankfort horizontal plane was 
delineated; B) Alar-facial line was delineated vertically; 
c,d) Dorsal radix height; (e-f) was measured by drawing 
a parallel line to Frankfort plane and a vertical line to 
alar – facial line, Then a–b and c–d distances were 
delineated and matched on the post-operation 
photographs, and distance of e–f on the post-operation 
photographs was measured. 
 Next, the preoperative dorsal height was 
subtracted from the values measured at 6 
and 12 months. Six groups were defined 
based on graft thickness: No absorption 
(thickness ≥ 0.6 mm); Low absorption (0.45 
mm ≤ thickness<0.6 mm); Moderate 
absorption (0.3 mm ≤ thickness < 0.45 mm); 
High absorption (0.15 mm ≤ thickness 
<0.3mm); Very high absorption (0< 
thickness< 0.15 mm); Complete absorption 
(≤ 0 mm). 
Twelve months after surgery, inspection 
and palpation of the nasal dorsum to identify 
irregularities was performed by a physician 
blinded with respect to the technique used in 
each patient. Based on this assessment, cases 
were classified into the following groups: 
very high irregularity, high, medium, low, 
very low, and no irregularity. 
At this 12-month visit, patient satisfaction 
with respect to irregularities of the nasal 
dorsum was also addressed using previously 
modified written forms based on five-point 
Likert scales (scores from 1 to 5). Patients 
were asked to rate satisfaction as very low, 
low, medium, high, or very high according 
to above scores by the same physician, and 
the responses were recorded. 
 
Statistical Analysis  
The data collected were analyzed by SPSS 
software 20, for quantitative variables 
between the two groups. Mean values and 
frequencies were estimated in each group. A 
t-test or Mann-Whitney test was used. The 
chi-square test or Fisher's exact test were 
used to analyze qualitative data. A P<0.05 
was considered statistically significant. 
 
Results 
Of 68 patients who underwent rhinoplasty 
surgery from March 2013 to 2015, 42 
completed the follow-up period. There were 
18 cases in the fascia lata group, of whom 
three (16.7%) were male; the acellular 
dermis group included 24 patients, of whom 
four (16.7%) were male. The age range was 
25–55 years (mean, 34.94±9.04 years) in the 
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homologous fascia lata group and 22–48 
years (mean, 31.25±6.93 years) in the 
acellular dermis group. No significant 
difference was found between the mean ages 
in the two groups (P=0.142). At Month 12, 
the results of inspection and palpation 
were better in the homologous fascia lata 
group compared with the acellular dermis 
group. On inspection in the homologous 
fascia lata group, 12 cases had no 
irregularity and six had a very low 
irregularity. Findings on palpation in the 
homologous fascia lata group showed nine 
patients had no irregularity and nine had 
very low irregularity (Fig.2).  
 
Fig 2: Patient from homologous fascia lata group; 
no irregularity (6 scores) on inspection and 
palpation; A) pre-OP; B) 6 months; C) 12 months. 
 
In contrast, on inspection in the acellular 
dermis group, the numbers of patients with 
no, very low, low, moderate irregularity 
were 12, two, six, and four, respectively. 
On palpation in this group, two, eight, six, 
four, and two patients, respectively, had 
no, very low, low, moderate, and high 
degrees of irregularity (Fig.3). 
 
Fig 3: Patient from acellular dermis graft group; 
low (4 scores) dorsal nasal irregularity on 
inspection and moderate (3 scores) on palpation. A) 
pre-OP; B) 6 months; C) 12 months. 
These differences were statistically 
significant with respect to palpation, but not 
inspection (Figs 4,5). 
 
Fig 4: Inspection findings (dorsal irregularity) after 
12 months of surgery; no significant difference 
between the two groups (P=0.06). 
 
Fig 5: Palpation findings (dorsal irregularity) after 
12 months of surgery; significant difference 
between the two groups (P = 0.00). 
Patient satisfaction was evaluated at Month 
12. In the homologous fascia lata group, of 
18 patients, six had a score of 5 and 12 had a 
score of 4. Among the 24 patients of the 
acellular dermis group, 11 declared a score 
of 4, 12 had a score of 3, and one had a score 
of 2. No scores of 5 were reported in the 
acellular dermis group. This improvement in 
the homologous fascia lata group was 
statistically significant according to the non-
parametric test analysis (P=0.00). The 
correlation coefficient test showed that   
there was a statistically significant 
correlation between the results of dorsum 
palpation and inspection in both group 
(P=0.001). Patient satisfaction and physician 
palpation showed a statistically significant 
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correlation in the acellular dermis group 
(P=0.009), but no correlation was found in 
the homologous fascia lata group  
(P=1.000). In comparison, the correlation 
between patient satisfaction and physician 
inspection was statistically significant in the 
homologous fascia lata group (P=0.024), 
while no such correlation was found in the 
acellular dermis group (P = 0.317). The 
results of absorption of the materials are 
shown in Table 1. 
 
Table 1: Comparison of absorption rate in the acellular dermis and fascia lata graft, 6 and 12 months after surgery. 
  None Low Moderate High Very high Complete 
Fascia 
Lata 











- 5 (27.8%) - 3(16.7%) 6 (33.3 %) 4(22.4%) 
Ceno- 
Derm 
6m 3 (12.5%) 
 
2 (8.3 %) 
 




5 (20.8 %) 
 
4(16.7% 
12m 3 (12.5%) - - 6 (25 %) 6 (25 %) 9 (37.5 %) 
        
There was no complete absorption in the 
fascia lata group at 6 months after surgery, 
and a statistically significant difference was 
found between the two groups at this time 
(P= 0.04). However, at the end of the Month 
12, complete absorption occurred in four 
cases (22.2%) in the fascia lata group, with 
no significant difference between the two 
groups (P= 0.386) (Figs 6,7). 
 
Fig 6: Patient from fascia lata graft group without 
absorption in 6 months and with low absorption at 
12 months; A) pre-OP; B) 6 months; C) 12 months.  
 
Fig 7: Patient from acellular dermis graft group; 
very high absorption at 6 months and complete. 
absorption at 12 months; A) pre-OP; B) 6 months; 
C) 12 months. 
Discussion 
Rhinoplasty operations are among the most 
common aesthetic procedures. Palpable 
dorsal irregularities are among the 
complications of rhinoplasty, and are more 
common in patients with thin skin (1). This 
problem can be a consequence of implant 
materials such as autografts, homografts, 
and alloplasts (2). In patients with thin skin, 
graft materials are occasionally used in 
primary rhinoplasty procedures for the 
prevention of visible dorsal nasal 
irregularities. Cartilage, dermis, temporal 
fascia, superficial musculoapo- neurotic 
system (SMAS), Vicryl mesh, gelatin film, 
polytetrafluoroethylene, Surgicel-wrapped 
diced and crushed cartilage, tensor fascia 
lata, and acellular dermis are among the 
most commonly used materials to correct 
contour deformities and provide a 
subcutaneous pad (1). Acellular dermis has 
been used in rhinoplasty for dorsal nasal 
irregularity, dorsal augmentation, and septal 
perforation. It has also been used for 
abdominal wall reconstruction in hernias, 
and in gum and lip augmentation. The 
complication rate associated with acellular 
dermis graft has been reported as more than 
20 percent in hernia repair surgery; 
similarly, complete absorption in lip 
augmentation has been reported (5-10). 
Similarly, homologous fascia lata has been 
used in orthopedic surgery as well as 
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abdominal and plastic surgery. Ophthalmic, 
gynecologic, and urologic surgeries are other 
uses, as well as use in stress incontinence, 
correction of congenital ptosis, and 
correction of facial nerve paralysis           
(11,12). The current study is the first 
designed to compare the outcomes of these 
two materials for the correction of dorsal 
nasal irregularities in rhinoplasty surgery. 
In other studies, the brand of acellular 
dermis used has tended to be AlloDerm. 
However, Iran has only recently launched 
production of this material, and the 
experience and research in this field is still 
very scarce. In our study the brand of 
acellular dermis used was CenoDerm.  
In this study, patients in neither group 
had complications such as infection, 
migration of material, extrusion, or seroma 
formation in the follow-up period. This is 
consistent with previous data (1). Only in 
one patient in the Gryskiewicz study was 
partial extrusion of AlloDerm reported. In 
this patient, the AlloDerm graft was rolled 
to form six layers and placed using an 
endonasal approach. More recently it is 
understood that stacking the grafts in 
layers is preferable to rolling the grafts to 
prevent postoperative migration (13). 
At the Month 6 postoperatively, there 
was no case of graft absorption in fascia 
group, but in at Month 12, it occurred 
completely in 16.7 percent of the patients.  
In the 2007 study by Ju Jang Y et al. 
designed to investigate Tutoplast-processed 
fascia lata for nasal dorsal augmentation in 
rhinoplasty, 69 patients were followed by 
photographs for 12 months after surgery. In 
41 patients, fascia lata without other material 
combination was used, and complete 
absorption occurred in 4.3% percent of this 
group (14). In our acellular dermis group, 
complete absorption was detected at both 6 
and 12 months; whereas after 12 months, it 
occurred in the fascia group only. A number 
of studies have been performed on the 
absorption rate of acellular dermis used for 
nasal dorsal irregularities. In the current 
study, quantitative parameters were used to 
describe the occurrence of absorption. 
However, in other studies, biopsy, 
pathology, and counter deformity 
assessment based on photographs have been 
used. In an animal study, pathology was 
used to assess graft absorption. This method 
is invasive and not practicable for our 
patients (14). In another study, contour 
deformity on photography was used without 
explanation of the assessment and 
measurement used. In this study, graft 
absorption was shown using quantitative 
parameters (13). The method used in one 
study concerning lip augmentation involved 
use of alar-base to lip point distances (9). 
The methodology used in our study was thus 
based on these studies, and in particular on 
the last one mentioned.  
In a prospective clinical animal study in 
rabbits, the absorption rate of acellular 
dermis for nasal dorsal irregularities was 
noted in 29.75% of cases. This result was 
achieved by biopsy 4 months after surgery 
(1). In another animal study investigating 
nasal dorsal irregularities, complete 
absorption of the acellular dermis 4 months 
after the graft was reported based on biopsy 
evaluation (15). 
In a study in 2005, 25 secondary 
rhinoplasty patients who underwent acellular 
dermis graft were followed for 2 years or 
longer. Long-term results showed minimal 
absorption. Absorption was most common 
over the bony dorsum, and was overall 
estimated at 20–30% of cases; 
approximately absorption occurred in 10–
15% of the patients over the tip. An 
evaluation was performed by means of 
photographic analysis (13). 
These studies demonstrate the different 
absorption rates via various estimation 
methods; although our results are not 
consistent with them. Of course, biopsy is 
a more precise, reliable method of 
evaluation, but invasiveness is a highly 
important issue and is not acceptable in a 
live patient after cosmetic plastic surgery. 
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As understood now, the efficacy of these 
materials is based on prevention of 
adhesion of the skin to the bone 
underneath (16).  
Better outcomes in the homologous fascia 
lata graft group can be associated with its 
non-absorption after 6 months and a slower 
absorption rate than the acellular dermis 
graft group between 6 and 12 months after 
surgery. This slower rate provides a 
sufficient time period for wound repair 
without any adhesions established between 
bone and the skin covering it, that are 
supposed to be the causes of dorsal nasal 
irregularity. Presence of skin edema might 
after 4 months potentially causes difficulty 
in assessment, and evaluation was therefore 
performed at Month 6 in our study. Based 
on previous studies, there was no 
relationship between absorption and the 
number of layers of the graft used; however, 
we used monolayer material in both           
groups (4).  
In a 2014 study by Dong Won Lee et al, 
two and three layers of acellular dermis 
were utilized for dorsal nasal augmentation 
in 20 patients in two groups. The degree of 
angiogenesis and the synthesis of collagen 
and elastin fibers were evaluated over 40 
days. Thickness decreased in both groups, 
but there was no statistically significant 
difference in volume (17). 
Poor patient cooperation for fulfillment 
of the follow-up sessions is an important 
issue in a group of cosmetic surgery 
patients that are highly satisfied with their 
outcomes. One patient from fascia group 
was excluded due to diagnosis of Wegner 
disease during her follow-up. Some 
patients were excluded because of no 
regular follow-up, with incomplete 
information and photography. A phone 
call was made to evaluate many of the 
patients that did not arrive at the Month 12 
assessment, and reasons provided included 
being far from the clinic because they live 
in another city of Iran, or traveling abroad. 
A busy work schedule was the reason 
among other patients. No response to our 
call phone led to incomplete follow-up and 
a lack of information in other patients, 
perhaps because the individual was 
satisfied with the shape of his or her nose. 
Despite providing consent for a 12-month 
follow-up, these patients did not return for 
objective evaluation and we were not able 
to analyze their data. Patient follow-up 
was worse in the fascia lata group, 
possibly due to better outcomes in this 
group.  
Longer-term follow-up evaluations of 
more than 12 months in a larger study 
population which included a control group 
who did not undergo any graft procedure 
would lead to more reliable results. 
 
Conclusion 
Despite the limitations of this study, use of 
homologous fascia lata appears preferable to 
acellular dermis graft in order to achieve 
lower rates of dorsal nasal irregularity in 
standard rhinoplasty surgery.  
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